• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯妥英在单一疗法和联合疗法中的结合参数。

Binding parameters of phenytoin during monotherapy and polytherapy.

作者信息

Pospísil J, Perlík F

机构信息

Department of Clinical Pharmacology, Charles University of Prague, Czechoslovakia.

出版信息

Int J Clin Pharmacol Ther Toxicol. 1992 Jan;30(1):24-8.

PMID:1348053
Abstract

The present in vivo study elucidated the effect of other commonly comedicated drugs on the phenytoin (PHT) Scatchard binding parameters. Specimens of 150 epileptic patients chronically treated with anticonvulsant drugs were analyzed. The results of covariance analysis suggest that phenobarbitone, ethosuximide, diazepam and folic acid do not alter binding of PHT to serum albumin. The contribution of carbamazepine and medazepam to the free fraction of PHT (decrease of about 0.4%) and/or Scatchard binding capacity (increase of about 1/3) is ambiguous and not statistically significant at the p less than 0.05 level. On the contrary, we found a statistically significant decrease of PHT binding in patients comedicated with valproic acid (VPA) and primidone (PRM). The decrease of about 25% in binding capacity evoked an increase of about 1% (VPA), and 1.5% (PRM), respectively in PHT free fraction.

摘要

本体内研究阐明了其他常用合并用药对苯妥英(PHT)Scatchard结合参数的影响。分析了150例长期接受抗惊厥药物治疗的癫痫患者的样本。协方差分析结果表明,苯巴比妥、乙琥胺、地西泮和叶酸不会改变PHT与血清白蛋白的结合。卡马西平和美达西泮对PHT游离分数(降低约0.4%)和/或Scatchard结合能力(增加约1/3)的影响不明确,在p小于0.05水平时无统计学意义。相反,我们发现合并使用丙戊酸(VPA)和扑米酮(PRM)的患者中PHT结合有统计学意义的降低。结合能力降低约25%分别导致PHT游离分数增加约1%(VPA)和1.5%(PRM)。

相似文献

1
Binding parameters of phenytoin during monotherapy and polytherapy.苯妥英在单一疗法和联合疗法中的结合参数。
Int J Clin Pharmacol Ther Toxicol. 1992 Jan;30(1):24-8.
2
Evaluation of therapeutic drug monitoring of antiepileptic drugs.抗癫痫药物的治疗药物监测评估
Int J Clin Pharmacol Ther. 2003 Mar;41(3):126-31.
3
Dose adjustment of phenytoin for comedication in Japanese patients with epilepsy.日本癫痫患者联合用药时苯妥英钠的剂量调整
Ther Drug Monit. 2009 Feb;31(1):57-62. doi: 10.1097/FTD.0b013e3181947772.
4
No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.抗癫痫药物对癫痫患者体内丙戊酸蛋白结合参数的影响。
J Pharm Pharmacol. 2011 Jul;63(7):976-81. doi: 10.1111/j.2042-7158.2011.01282.x.
5
Serum protein binding of antiepileptic drugs in Sri Lankans.斯里兰卡人抗癫痫药物的血清蛋白结合情况
Ceylon Med J. 1990 Mar;35(1):25-8.
6
PB:PRM ratio in patients with epilepsy treated with primidone.使用扑米酮治疗的癫痫患者的PB:PRM比率
Int J Clin Pharmacol Res. 1983;3(3):185-93.
7
[Therapeutic ranges of anti-epileptic drugs in monotherapy of children].
An Esp Pediatr. 1991 Jan;34(1):32-42.
8
Modelling of the pharmacodynamic interaction between phenytoin and sodium valproate.苯妥英钠与丙戊酸钠药效学相互作用的模型构建
Br J Pharmacol. 1998 Dec;125(7):1610-6. doi: 10.1038/sj.bjp.0702235.
9
Therapeutic drug monitoring of antiepileptic drugs.抗癫痫药物的治疗药物监测
JNMA J Nepal Med Assoc. 2008 Jul-Sep;47(171):94-7.
10
[Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].[接受卡马西平、丙戊酸或苯妥英治疗的成年癫痫患者的血脂、脂蛋白和载脂蛋白]
Rev Neurol. 1998 Nov;27(159):785-9.

引用本文的文献

1
Factors affecting the free plasma fraction of phenytoin in patients with epilepsy.影响癫痫患者苯妥英游离血浆分数的因素。
Clin Drug Investig. 1998;15(2):153-7. doi: 10.2165/00044011-199815020-00008.